Subscribe To
AERI / Aerie Pharmaceuticals (AERI) Stock: Why It Substantially Increased
Content Topics
United
Communications
Partners
Inc
Ucpa
Pharmaceuticals
aeri
Stock
Substantially
Increased
Stock
AERI
AERI News
By Zacks Investment Research
November 3, 2022
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates
Aerie (AERI) delivered earnings and revenue surprises of 35.71% and 2.91%, respectively, for the quarter ended September 2022. Do the numbers hold clu more_horizontal
By The Motley Fool
August 26, 2022
Why Aerie Pharmaceuticals Was Soaring So High This Week
You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you. more_horizontal
By Seeking Alpha
August 7, 2022
Aerie Pharmaceuticals, Inc.'s (AERI) CEO Raj Kannan on Q2 2022 Results - Earnings Call Transcript
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Hans Vitzthum – Investor more_horizontal
By Zacks Investment Research
May 25, 2022
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye diseas more_horizontal
By Seeking Alpha
May 7, 2022
Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Part more_horizontal
By Zacks Investment Research
May 6, 2022
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
Aerie (AERI) misses on both earnings and revenues for the first quarter of 2022. more_horizontal
By Zacks Investment Research
May 5, 2022
Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates
Aerie (AERI) delivered earnings and revenue surprises of -1.54% and 1.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues t more_horizontal
By Pulse2
February 27, 2022
Aerie Pharmaceuticals (AERI) Stock: Why It Substantially Increased
The Aerie Pharmaceuticals Inc (NASDAQ: AERI) stock increased by 29.49% in the most recent trading session. This is why. more_horizontal